What is the Return on Assets (ROA) of Merck & Co this year?
The Return on Assets (ROA) of Merck & Co is 0 undefined this year.
Merck & Co ROA 2024
Merck & Co ROA
0
Merck & Co Dividend yield
2.36 %
Ticker
MRK
ISIN
US58933Y1055
WKN
A0YD8Q
In 2024, Merck & Co's return on assets (ROA) was 0, a -97.43% increase from the 0.13 ROA in the previous year.
Merck & Co Aktienanalyse
What does Merck & Co do?
The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding Merck & Co's Return on Assets (ROA)
Merck & Co's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing Merck & Co's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider Merck & Co's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in Merck & Co’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about Merck & Co Stock
What was the ROA of Merck & Co compared to the previous year?
The ROA of Merck & Co has increased by -97.43% compared to the previous year.
What consequences do high ROA have for investors of Merck & Co?
A high ROA is advantageous for investors of Merck & Co, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in Merck & Co?
A low ROA can be unfavorable for investors of Merck & Co as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of Merck & Co affect the company?
An increase in ROA of Merck & Co can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of Merck & Co impact the company?
A reduction in the ROA of Merck & Co can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of Merck & Co?
Some factors that can influence the ROA of Merck & Co include revenue, operating costs, asset structure, and industry average.
Why is the ROA of Merck & Co important for investors?
The ROA of Merck & Co is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can Merck & Co take to improve ROA?
To improve ROA, Merck & Co can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does Merck & Co pay?
Over the past 12 months, Merck & Co paid a dividend of 2.96 USD . This corresponds to a dividend yield of about 2.36 %. For the coming 12 months, Merck & Co is expected to pay a dividend of 3.37 USD.
What is the dividend yield of Merck & Co?
The current dividend yield of Merck & Co is 2.36 %.
When does Merck & Co pay dividends?
Merck & Co pays a quarterly dividend. This is distributed in the months of July, October, January, April.
How secure is the dividend of Merck & Co?
Merck & Co paid dividends every year for the past 26 years.
What is the dividend of Merck & Co?
For the upcoming 12 months, dividends amounting to 3.37 USD are expected. This corresponds to a dividend yield of 2.7 %.
In which sector is Merck & Co located?
Merck & Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Merck & Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Merck & Co from 4/5/2024 amounting to 0.77 USD, you needed to have the stock in your portfolio before the ex-date on 3/14/2024.
When did Merck & Co pay the last dividend?
The last dividend was paid out on 4/5/2024.
What was the dividend of Merck & Co in the year 2023?
In the year 2023, Merck & Co distributed 2.8 USD as dividends.
In which currency does Merck & Co pay out the dividend?
The dividends of Merck & Co are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Merck & Co stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Merck & Co
Our stock analysis for Merck & Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck & Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
